ALLR

ALLR

USD

Allarity Therapeutics Inc. Common Stock

$1.295-0.035 (-2.632%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.330

Hoch

$1.340

Tief

$1.280

Volumen

0.38M

Unternehmensfundamentaldaten

Marktkapitalisierung

18.8M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

7.00M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.614Aktuell $1.295Hoch $2.35

Ähnliche Nachrichten

Analyst Upgrades

Ascendiant Capital Maintains Buy on Allarity Therapeutics, Raises Price Target to $9.25

Ascendiant Capital analyst Edward Woo maintains Allarity Therapeutics with a Buy and raises the price target from $9 to $9.25.

Mehr anzeigen
Ascendiant Capital Maintains Buy on Allarity Therapeutics, Raises Price Target to $9.25
GlobeNewswire

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months

- Kaplan-Meier analyses show for the first time that median Overall Survival exceeds 25 months for Platinum Resistant and Refractory Ovarian Cancer Patients receiving stenoparib/2X-121 twice daily - Two patients

Mehr anzeigen
Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months